位置:首页 > 蛋白库 > BRG11_RALSO
BRG11_RALSO
ID   BRG11_RALSO             Reviewed;        1245 AA.
AC   Q8XYE3;
DT   29-OCT-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   25-MAY-2022, entry version 90.
DE   RecName: Full=TAL effector protein Brg11 {ECO:0000305};
GN   Name=brg11 {ECO:0000303|PubMed:15225308};
GN   Synonyms=RTL2 {ECO:0000303|PubMed:23300258}; OrderedLocusNames=RSc1815;
OS   Ralstonia solanacearum (strain GMI1000) (Pseudomonas solanacearum).
OC   Bacteria; Proteobacteria; Betaproteobacteria; Burkholderiales;
OC   Burkholderiaceae; Ralstonia.
OX   NCBI_TaxID=267608;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=GMI1000;
RX   PubMed=11823852; DOI=10.1038/415497a;
RA   Salanoubat M., Genin S., Artiguenave F., Gouzy J., Mangenot S., Arlat M.,
RA   Billault A., Brottier P., Camus J.-C., Cattolico L., Chandler M.,
RA   Choisne N., Claudel-Renard C., Cunnac S., Demange N., Gaspin C., Lavie M.,
RA   Moisan A., Robert C., Saurin W., Schiex T., Siguier P., Thebault P.,
RA   Whalen M., Wincker P., Levy M., Weissenbach J., Boucher C.A.;
RT   "Genome sequence of the plant pathogen Ralstonia solanacearum.";
RL   Nature 415:497-502(2002).
RN   [2]
RP   INDUCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=GMI1000;
RX   PubMed=15225308; DOI=10.1111/j.1365-2958.2004.04118.x;
RA   Cunnac S., Occhialini A., Barberis P., Boucher C., Genin S.;
RT   "Inventory and functional analysis of the large Hrp regulon in Ralstonia
RT   solanacearum: identification of novel effector proteins translocated to
RT   plant host cells through the type III secretion system.";
RL   Mol. Microbiol. 53:115-128(2004).
RN   [3]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=GMI1000;
RX   PubMed=20687809; DOI=10.1094/mpmi-23-9-1197;
RA   Macho A.P., Guidot A., Barberis P., Beuzon C.R., Genin S.;
RT   "A competitive index assay identifies several Ralstonia solanacearum type
RT   III effector mutant strains with reduced fitness in host plants.";
RL   Mol. Plant Microbe Interact. 23:1197-1205(2010).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, BIOTECHNOLOGY, REPEAT, DNA-BINDING,
RP   AND MUTAGENESIS OF LYS-615; ASN-685; LYS-720 AND 1213-THR--THR-1245.
RX   PubMed=23692030; DOI=10.1111/nph.12324;
RA   de Lange O., Schreiber T., Schandry N., Radeck J., Braun K.H.,
RA   Koszinowski J., Heuer H., Strauss A., Lahaye T.;
RT   "Breaking the DNA-binding code of Ralstonia solanacearum TAL effectors
RT   provides new possibilities to generate plant resistance genes against
RT   bacterial wilt disease.";
RL   New Phytol. 199:773-786(2013).
RN   [5]
RP   SUBCELLULAR LOCATION, DOMAIN, BIOTECHNOLOGY, AND REPEAT.
RX   PubMed=23300258; DOI=10.1093/mp/sst006;
RA   Li L., Atef A., Piatek A., Ali Z., Piatek M., Aouida M., Sharakuu A.,
RA   Mahjoub A., Wang G., Khan S., Fedoroff N.V., Zhu J.K., Mahfouz M.M.;
RT   "Characterization and DNA-binding specificities of Ralstonia TAL-like
RT   effectors.";
RL   Mol. Plant 6:1318-1330(2013).
RN   [6]
RP   BIOTECHNOLOGY USES REVIEW.
RX   PubMed=24602153; DOI=10.1111/tpj.12431;
RA   de Lange O., Binder A., Lahaye T.;
RT   "From dead leaf, to new life: TAL effectors as tools for synthetic
RT   biology.";
RL   Plant J. 78:753-771(2014).
CC   -!- FUNCTION: Exported into plant cells, where it is targeted to the
CC       nucleus and probably acts as a transcription factor. Binds DNA in a
CC       sequence-specific manner. May contribute to plant pathogenicity.
CC       {ECO:0000269|PubMed:20687809, ECO:0000269|PubMed:23692030}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P14727}. Host
CC       nucleus {ECO:0000269|PubMed:23300258, ECO:0000269|PubMed:23692030}.
CC       Note=Secreted via type III secretion system (TTSS).
CC       {ECO:0000250|UniProtKB:Q68A49}.
CC   -!- INDUCTION: Regulated by hrpB, which controls the type III secretion
CC       system. {ECO:0000269|PubMed:15225308}.
CC   -!- DOMAIN: The central DNA-binding region is composed of 16 tandem core
CC       repeats with 1 base-specifying residue (BSR residue 13, also called
CC       repeat variable diresidue, RVD, residues 12 and 13). The BSR is
CC       probably the only residue to contact DNA in a sequence-specific manner,
CC       although other repeat residues effect repeat activity and specificity.
CC       {ECO:0000269|PubMed:23692030, ECO:0000303|PubMed:23300258}.
CC   -!- DOMAIN: There are at least 4 possible nuclear localization signals,
CC       both N- and C-terminal regions contribute to nuclear localization.
CC       {ECO:0000250|UniProtKB:Q68A49}.
CC   -!- DOMAIN: The C-terminus encodes a plant transcriptional activation
CC       domain. Replacement of the 295 last residues of AvrBs3 (AC P14727) with
CC       the same region of this protein activates transcription in transformed
CC       N.benthamiana leaves. {ECO:0000269|PubMed:23692030}.
CC   -!- DISRUPTION PHENOTYPE: No alteration in pathogenicity on tomato
CC       (S.lycopersicum cv Supermarmande) (PubMed:15225308), another study
CC       found decreased pathogenicity on eggplant (S.melongena cv. Zebrina,
CC       PubMed:20687809). {ECO:0000269|PubMed:15225308,
CC       ECO:0000269|PubMed:20687809}.
CC   -!- BIOTECHNOLOGY: By combining the DNA-binding domain with the catalytic
CC       domain of the restriction endonuclease FokI, TALE-nuclease (TALEN)
CC       enzymes able to target specific dsDNA sequences are created that enable
CC       eukaryotic genome modification. Other potential uses as transcriptional
CC       repressors, for transposon targeting, DNA methylation or histone tail
CC       modifictions are also possible. {ECO:0000303|PubMed:23300258,
CC       ECO:0000303|PubMed:23692030, ECO:0000303|PubMed:24602153}.
CC   -!- SIMILARITY: Belongs to the transcription activator-like effector (TALE)
CC       family. RipTAL/RTL subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL646052; CAD15517.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q8XYE3; -.
DR   SMR; Q8XYE3; -.
DR   STRING; 267608.RSc1815; -.
DR   PRIDE; Q8XYE3; -.
DR   EnsemblBacteria; CAD15517; CAD15517; RSc1815.
DR   KEGG; rso:RSc1815; -.
DR   PATRIC; fig|267608.8.peg.1857; -.
DR   eggNOG; COG2201; Bacteria.
DR   HOGENOM; CLU_003229_1_0_4; -.
DR   OMA; SHNGGKQ; -.
DR   PHI-base; PHI:2922; -.
DR   PHI-base; PHI:5143; -.
DR   PHI-base; PHI:5179; -.
DR   Proteomes; UP000001436; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   InterPro; IPR005042; TAL_effector_rpt.
DR   Pfam; PF03377; TAL_effector; 17.
PE   1: Evidence at protein level;
KW   DNA-binding; Host nucleus; Reference proteome; Repeat; Secreted;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..1245
FT                   /note="TAL effector protein Brg11"
FT                   /id="PRO_0000430627"
FT   REPEAT          286..320
FT                   /note="Cryptic repeat -1"
FT                   /evidence="ECO:0000303|PubMed:23300258,
FT                   ECO:0000303|PubMed:23692030"
FT   REPEAT          321..354
FT                   /note="Cryptic repeat 0"
FT                   /evidence="ECO:0000303|PubMed:23300258,
FT                   ECO:0000303|PubMed:23692030"
FT   REPEAT          355..389
FT                   /note="Core repeat 1"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          390..424
FT                   /note="Core repeat 2"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          425..459
FT                   /note="Core repeat 3"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          460..494
FT                   /note="Core repeat 4"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          495..529
FT                   /note="Core repeat 5"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          530..564
FT                   /note="Core repeat 6"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          565..599
FT                   /note="Core repeat 7"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          600..634
FT                   /note="Core repeat 8"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          635..669
FT                   /note="Core repeat 9"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          670..704
FT                   /note="Core repeat 10"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          705..739
FT                   /note="Core repeat 11"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          740..774
FT                   /note="Core repeat 12"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          775..809
FT                   /note="Core repeat 13"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          810..844
FT                   /note="Core repeat 14"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          845..879
FT                   /note="Core repeat 15"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          880..914
FT                   /note="Core repeat 16"
FT                   /evidence="ECO:0000303|PubMed:15225308,
FT                   ECO:0000303|PubMed:23300258"
FT   REPEAT          915..948
FT                   /note="Cryptic repeat +1"
FT                   /evidence="ECO:0000303|PubMed:23692030"
FT   REPEAT          949..982
FT                   /note="Cryptic repeat +2"
FT                   /evidence="ECO:0000303|PubMed:23692030"
FT   REGION          1..87
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          173..205
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1096..1138
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1237..1245
FT                   /note="Activation domain"
FT                   /evidence="ECO:0000303|PubMed:23692030"
FT   MOTIF           185..191
FT                   /note="Nuclear localization signal 1"
FT                   /evidence="ECO:0000250|UniProtKB:Q68A49"
FT   MOTIF           980..983
FT                   /note="Nuclear localization signal 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q68A49"
FT   MOTIF           1108..1111
FT                   /note="Nuclear localization signal 3"
FT                   /evidence="ECO:0000250|UniProtKB:Q68A49"
FT   MOTIF           1145..1148
FT                   /note="Nuclear localization signal 4"
FT                   /evidence="ECO:0000250|UniProtKB:Q68A49"
FT   COMPBIAS        22..42
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        68..87
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         615
FT                   /note="K->N: Decreased promoter activation in plants; when
FT                   associated with N-720."
FT                   /evidence="ECO:0000269|PubMed:23692030"
FT   MUTAGEN         685
FT                   /note="N->K: Increased promoter activation in plants."
FT                   /evidence="ECO:0000269|PubMed:23692030"
FT   MUTAGEN         720
FT                   /note="K->N: Decreased promoter activation in plants; when
FT                   associated with N-615."
FT                   /evidence="ECO:0000269|PubMed:23692030"
FT   MUTAGEN         1213..1245
FT                   /note="Missing: Loss of transcription activation by an
FT                   AvrBs3-Brg11 chimera in plants."
FT                   /evidence="ECO:0000269|PubMed:23692030"
SQ   SEQUENCE   1245 AA;  130712 MW;  DCF30BB20411110E CRC64;
     MRIGKSSGWL NESVSLEYEH VSPPTRPRDT RRRPRAAGDG GLAHLHRRLA VGYAEDTPRT
     EARSPAPRRP LPVAPASAPP APSLVPEPPM PVSLPAVSSP RFSAGSSAAI TDPFPSLPPT
     PVLYAMAREL EALSDATWQP AVPLPAEPPT DARRGNTVFD EASASSPVIA SACPQAFASP
     PRAPRSARAR RARTGGDAWP APTFLSRPSS SRIGRDVFGK LVALGYSREQ IRKLKQESLS
     EIAKYHTTLT GQGFTHADIC RISRRRQSLR VVARNYPELA AALPELTRAH IVDIARQRSG
     DLALQALLPV ATALTAAPLR LSASQIATVA QYGERPAIQA LYRLRRKLTR APLHLTPQQV
     VAIASNTGGK RALEAVCVQL PVLRAAPYRL STEQVVAIAS NKGGKQALEA VKAHLLDLLG
     APYVLDTEQV VAIASHNGGK QALEAVKADL LDLRGAPYAL STEQVVAIAS HNGGKQALEA
     VKADLLELRG APYALSTEQV VAIASHNGGK QALEAVKAHL LDLRGVPYAL STEQVVAIAS
     HNGGKQALEA VKAQLLDLRG APYALSTAQV VAIASNGGGK QALEGIGEQL LKLRTAPYGL
     STEQVVAIAS HDGGKQALEA VGAQLVALRA APYALSTEQV VAIASNKGGK QALEAVKAQL
     LELRGAPYAL STAQVVAIAS HDGGNQALEA VGTQLVALRA APYALSTEQV VAIASHDGGK
     QALEAVGAQL VALRAAPYAL NTEQVVAIAS SHGGKQALEA VRALFPDLRA APYALSTAQL
     VAIASNPGGK QALEAVRALF RELRAAPYAL STEQVVAIAS NHGGKQALEA VRALFRGLRA
     APYGLSTAQV VAIASSNGGK QALEAVWALL PVLRATPYDL NTAQIVAIAS HDGGKPALEA
     VWAKLPVLRG APYALSTAQV VAIACISGQQ ALEAIEAHMP TLRQASHSLS PERVAAIACI
     GGRSAVEAVR QGLPVKAIRR IRREKAPVAG PPPASLGPTP QELVAVLHFF RAHQQPRQAF
     VDALAAFQAT RPALLRLLSS VGVTEIEALG GTIPDATERW QRLLGRLGFR PATGAAAPSP
     DSLQGFAQSL ERTLGSPGMA GQSACSPHRK RPAETAIAPR SIRRSPNNAG QPSEPWPDQL
     AWLQRRKRTA RSHIRADSAA SVPANLHLGT RAQFTPDRLR AEPGPIMQAH TSPASVSFGS
     HVAFEPGLPD PGTPTSADLA SFEAEPFGVG PLDFHLDWLL QILET
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024